相似文献
1
Common idiopathic pulmonary fibrosis risk variants are associated with hypersensitivity pneumonitis.
Thorax. 2022 May;77(5):508-510. doi: 10.1136/thoraxjnl-2021-217693. Epub 2022 Jan 7.
2
The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.
Lancet Respir Med. 2017 Aug;5(8):639-647. doi: 10.1016/S2213-2600(17)30216-3. Epub 2017 Jun 22.
3
Single Nucleotide Polymorphisms (SNP) and SNP-SNP Interactions of the Surfactant Protein Genes Are Associated With Idiopathic Pulmonary Fibrosis in a Mexican Study Group; Comparison With Hypersensitivity Pneumonitis.
Front Immunol. 2022 Jun 2;13:842745. doi: 10.3389/fimmu.2022.842745. eCollection 2022.
4
Acute Exacerbation and Proposed Criteria for Progressive Pulmonary Fibrosis in Patients with Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis.
Respiration. 2023;102(9):803-812. doi: 10.1159/000533312. Epub 2023 Aug 24.
5
The new useful high-resolution computed tomography finding for diagnosing fibrotic hypersensitivity pneumonitis: "hexagonal pattern": a single-center retrospective study.
BMC Pulm Med. 2022 Mar 4;22(1):76. doi: 10.1186/s12890-022-01869-4.
6
[Comparative pathomorphological characteristics of idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis].
Arkh Patol. 2022;84(1):59-66. doi: 10.17116/patol20228401159.
7
Features of transbronchial lung cryobiopsy-diagnosed fibrotic hypersensitivity pneumonitis.
Clin Respir J. 2023 Jan;17(1):50-58. doi: 10.1111/crj.13561. Epub 2022 Nov 17.
8
Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1.
BMC Pulm Med. 2014 Jul 26;14:120. doi: 10.1186/1471-2466-14-120.
9
Impact of radiographic honeycombing on transplant free survival and efficacy of immunosuppression in fibrotic hypersensitivity pneumonitis.
BMC Pulm Med. 2023 Jun 22;23(1):224. doi: 10.1186/s12890-023-02523-3.
10
The Presence of T Allele (rs35705950) of the MUC5B Gene Predicts Lower Baseline Forced Vital Capacity and Its Subsequent Decline in Patients with Hypersensitivity Pneumonitis.
Int J Mol Sci. 2023 Jun 28;24(13):10748. doi: 10.3390/ijms241310748.
引用本文的文献
1
Pathophysiological Insights and Clinical Management Strategies for Interstitial Lung Diseases.
Biomol Ther (Seoul). 2025 Sep 1;33(5):785-803. doi: 10.4062/biomolther.2025.003. Epub 2025 Aug 14.
2
Germline Whole-Exome Sequencing in Non-Smoker Lung Cancer Patients Reveals Pathogenic Variants in Lung Cancer Driver Genes.
Genes Chromosomes Cancer. 2025 Mar;64(3):e70040. doi: 10.1002/gcc.70040.
3
Fibrosis: cross-organ biology and pathways to development of innovative drugs.
Nat Rev Drug Discov. 2025 Mar 18. doi: 10.1038/s41573-025-01158-9.
4
Genetic Risk Factors in Idiopathic and Non-Idiopathic Interstitial Lung Disease: Similarities and Differences.
Medicina (Kaunas). 2024 Nov 29;60(12):1967. doi: 10.3390/medicina60121967.
5
Genotype and Other Common Variants Are Associated with Computational Imaging Features of Usual Interstitial Pneumonia.
Ann Am Thorac Soc. 2025 Apr;22(4):533-540. doi: 10.1513/AnnalsATS.202401-022OC.
6
The Dawn of Precision Medicine in Fibrotic Interstitial Lung Disease.
Chest. 2025 Apr;167(4):1120-1132. doi: 10.1016/j.chest.2024.10.042. Epub 2024 Nov 8.
7
Air Pollution Exposure and Interstitial Lung Features in SPIROMICS Participants with Chronic Obstructive Pulmonary Disease.
Ann Am Thorac Soc. 2024 Sep;21(9):1251-1260. doi: 10.1513/AnnalsATS.202308-741OC.
8
Tetrahedral DNA loaded siCCR2 restrains M1 macrophage polarization to ameliorate pulmonary fibrosis in chemoradiation-induced murine model.
Mol Ther. 2024 Mar 6;32(3):766-782. doi: 10.1016/j.ymthe.2024.01.022. Epub 2024 Jan 24.
9
GDF15 as a potential biomarker to distinguish fibrotic from non-fibrotic hypersensitivity pneumonitis.
Sci Rep. 2024 Jan 9;14(1):859. doi: 10.1038/s41598-023-49459-6.
10
The Presence of T Allele (rs35705950) of the MUC5B Gene Predicts Lower Baseline Forced Vital Capacity and Its Subsequent Decline in Patients with Hypersensitivity Pneumonitis.
Int J Mol Sci. 2023 Jun 28;24(13):10748. doi: 10.3390/ijms241310748.
本文引用的文献
1
Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guideline and Expert Panel Report.
Chest. 2021 Aug;160(2):e97-e156. doi: 10.1016/j.chest.2021.03.066. Epub 2021 Apr 20.
2
Molecular markers of telomere dysfunction and senescence are common findings in the usual interstitial pneumonia pattern of lung fibrosis.
Histopathology. 2021 Jul;79(1):67-76. doi: 10.1111/his.14334. Epub 2021 Apr 14.
3
Hypersensitivity pneumonitis.
Nat Rev Dis Primers. 2020 Aug 6;6(1):65. doi: 10.1038/s41572-020-0191-z.
4
Genome-Wide Association Study: Functional Variant rs2076295 Regulates Desmoplakin Expression in Airway Epithelial Cells.
Am J Respir Crit Care Med. 2020 Nov 1;202(9):1225-1236. doi: 10.1164/rccm.201910-1958OC.
5
The promoter risk allele for idiopathic pulmonary fibrosis predisposes to asbestosis.
Eur Respir J. 2020 Apr 30;55(4). doi: 10.1183/13993003.02361-2019. Print 2020 Apr.
6
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med. 2020 Mar 1;201(5):564-574. doi: 10.1164/rccm.201905-1017OC.
7
Rare Protein-Altering Telomere-related Gene Variants in Patients with Chronic Hypersensitivity Pneumonitis.
Am J Respir Crit Care Med. 2019 Nov 1;200(9):1154-1163. doi: 10.1164/rccm.201902-0360OC.
8
Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med. 2019 Jul 15;200(2):199-208. doi: 10.1164/rccm.201810-1891OC.
9
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
N Engl J Med. 2018 Dec 6;379(23):2209-2219. doi: 10.1056/NEJMoa1801562. Epub 2018 Oct 20.
10
Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis: An International Modified Delphi Survey.
Am J Respir Crit Care Med. 2018 Apr 15;197(8):1036-1044. doi: 10.1164/rccm.201710-1986OC. Epub 2017 Nov 27.
Zotero 插件